Expert Review of Clinical Pharmacology

Papers
(The TQCC of Expert Review of Clinical Pharmacology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Personalizing tamoxifen therapy in adjuvant therapy: a brief summary of the ongoing discussion53
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysis52
A review of current and emerging therapies in breast cancer: implications for older adults40
Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed39
Prostate cancer and novel pharmacological treatment options–what’s new for 2022?36
Clinical pharmacology of antiplatelet drugs35
Reducing the risk of death – a possible outcome in COPD patients34
Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions34
Sparsentan: a dual endothelin and angiotensin II receptor antagonist approved for IgA nephropathy33
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments31
A simulation study to assess the influence of population pharmacokinetic model selection on Bayesian forecasting of vancomycin exposure in preterm neonates29
Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies28
Management of polypharmacy through deprescribing in older patients: a review of the role of AI tools27
Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?26
What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion24
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome24
Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis23
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria22
Cannabidiol drug interaction considerations for prescribers and pharmacists22
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review22
Amylin analogs for the treatment of obesity without diabetes: present and future21
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection21
Medical management of pediatric chronic rhinosinusitis21
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy20
Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials20
Role of tenecteplase in ischemic stroke after 4.5 hours: an evaluation of the TRACE-III trial19
Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspective18
Reply to: The risk for genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter?18
Treatment management for rosacea: current pharmacological and non-pharmacological options18
Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study17
Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era17
The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease16
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape16
CYP2C19 genotype-guided dosing of proton pump inhibitors: progress in clinical trials and real-world use16
Intestinal microbiome and epilepsy: a new therapeutic approach?16
Pharmacological strategies for the management of the antisocial personality disorder16
Reconsidering molecular pathways in giant benign prostatic hyperplasia: a potential strategy for an unmet challenge16
Clinical pharmacology of SGLT-2 inhibitors in heart failure16
OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability16
Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis15
Recent advances and unmet needs in the treatment of drug-resistant tuberculosis15
Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management15
Population pharmacokinetic modeling and exposure-response analysis of anrikefon: insights and implications in clinical analgesia15
Innovation in pediatric atopic dermatitis care: examining emerging topical treatment options14
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis14
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia14
Clozapine for older adults with severe mental illness: a systematic review and expert recommendations for clinical practice14
Current and emerging pharmacotherapies for treating vascular malformations14
Population pharmacokinetic modeling of piperacillin in critically ill adult patients: consideration of sex-based differences during model development14
A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy14
Pharmacogenomics – a minor rather than major force in clinical medicine14
FLOT vs CROSS in localized esophageal adenocarcinoma: what is the current best strategy?14
Hydroxyurea in the sickle cell disease modern era14
Methotrexate polyglutamates13
Osteoarthritis and cardiometabolic diseases: shared mechanisms, modifiable risk factors, and integrated management strategies13
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review13
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of adalimumab in patients with juvenile idiopathic arthritis13
Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshop13
Methenamine Hippurate in UTI management: a reemerging pharmacological strategy13
Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis12
Phosphatidylinositol 3 kinase inhibitor-related pneumonitis: a systematic review and meta-analysis12
Progress in the pharmacological management of vasovagal syncope12
The nocebo phenomenon in the COVID-19 pandemic: a nocebodemic effect12
Designer benzodiazepines: an update12
Efficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials12
Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options12
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry11
Pharmacotherapy for previously treated gastric cancer patients: current options and future developments11
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)11
A systematic review and meta-analysis of users versus non-users: unveiling the influence of proton pump inhibitors on capecitabine efficacy in colorectal cancer11
Optimization of secukinumab dose regimens in patients with moderate-to-severe plaque psoriasis via exposure-response modeling11
Biosimilars for chronic plaque psoriasis: a 2026 update11
Pharmacokinetic interaction of quetiapine and lamotrigine – victim and perpetrator?11
Biomarker discovery in acetaminophen hepatotoxicity: leveraging single-cell transcriptomics and mechanistic insight10
Genito-urinary infectious adverse events related to sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression10
Comparison of dopamine D2 receptor occupancy profiles between risperidone ISM versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulations10
Revolutionizing diabetes care: unveiling tirzepatide’s potential in glycemic control and beyond10
Interstitial lung disease associated with anti-HER2 anti-body drug conjugates: results from clinical trials and the WHO's pharmacovigilance database10
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis10
TYK2 as a novel therapeutic target in psoriasis10
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis10
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future10
Dasiglucagon for treating severe hypoglycemia in patients with diabetes10
PREG-ADR: development and validation of a predictive tool for adverse drug reactions in hospitalized pregnant women10
Signal mining study of severe cutaneous adverse events of valaciclovir or acyclovir based on the FAERS database10
Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up10
Clinical pharmacology of siRNA therapeutics: current status and future prospects10
Psychedelic drugs for the treatment of substance use disorders10
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock9
The orexin system and alcohol use disorder: bridging the gap between preclinical and clinical research9
Current understanding of the etiology of cyclic vomiting syndrome and therapeutic strategies in its management9
Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus9
Hormonal contraception, past, present, and future part 1: the early path – facts, stories, and controversies9
Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system9
Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare system9
Clozapine for treatment refractory catatonia in individuals with autism spectrum disorder: a retrospective chart review study9
The future of pharmacology education: The Veterinary Educators in Pharmacology Special Interest Group (VEPSIG)9
Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses9
Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan9
Adverse clinical outcomes associated with drug-related hospitalizations in people with dementia9
Pharmacological treatment for transforming growth factor beta induced corneal dystrophies: what is the way forward?8
Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis8
Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective8
Intravitreal immunotherapy in non-infectious uveitis: an update8
Detrimental impact of gastric acid suppressants on vascular endothelial growth factor receptor tyrosine kinase inhibitors efficacy: evidence from a systematic review and meta-analysis8
Predictors of warfarin therapeutic dose across thromboembolic indications: an exploratory early clinical evaluation study using machine learning-integrated explainable artificial intelligence and Baye8
Novel and emerging treatment strategies for lupus nephritis8
Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia8
Reliance is key to effective access and oversight of medical products in case of public health emergencies8
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin8
Considerations when prescribing opioid agonist therapies for people living with HIV8
1.1591839790344